Is COL11A1 p.Pro582Ser (c.1744C>T) pathogenic?

COL11A1 p.Pro582Ser (c.1744C>T) is classified Conflicting classifications of pathogenicity in COL11A1 (ClinVar, Conflicting submitters, 3 submitters; last evaluated 2024-09-30). AlphaMissense: likely benign (0.064); Ultra-rare (popmax 0.0164%, mid).

How common is COL11A1 p.Pro582Ser (c.1744C>T) in the general population?

COL11A1 p.Pro582Ser (c.1744C>T) is ultra-rare (popmax 0.0164%, mid) (gnomAD).

What do computational predictors say about COL11A1 p.Pro582Ser (c.1744C>T)?

AlphaMissense predicts likely benign (score 0.064) — an in-silico prediction, not a clinical call.

COL11A1 p.Pro582Ser

c.1744C>T · rs746192125 · VCV1207783

Conflicting classifications of pathogenicity Conflicting submitters

Classification

Conflicting classifications of pathogenicity

ClinVar

Review

Conflicting submitters ★☆☆☆

ClinVar · 3 submitters

AlphaMissense

likely benign

0.064 · ACMG-weighted

gnomAD v4.1

Rare

ultra-rare (popmax 0.0164%, mid)

Missense predictors

0/2 damaging

AlphaMissense, SaProt · REVEL no call

Computational evidence

Protein change
AlphaMissense	0.064	likely benign
REVEL	0.377	indeterminate
SaProt	LLR -8.15	tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Pangolin	Δ0.22	loss · gain 0.01 · not in the SpliceAI release · independent
Constraint at this position
Conservation	phyloP 8.5	GERP 1.8, phastCons 1
Regional constraint	o/e 0.96	unconstrained · MANE · 230 kb · p 0.038 · regional, not allelic
Overall
CADD	23.5	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0164% Middle Eastern · 1/6,082 alleles

Filtering AF 0.00226% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00135%

Overall 0.000744% 12/1,613,440 alleles · ultra-rare

Ancestry group	Frequency	1 in
Middle Easterngrpmax	0.0164%	6,082
Admixed American	0.00667%	14,987
South Asian	0.0022%	45,532
Remaining individualsnot grpmax-eligible	0.0016%	62,460
African / African-American	0.00134%	74,796
European (non-Finnish)	0.000254%	393,281

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: COL11A1
Protein: p.Pro582Ser
Coding: c.1744C>T
MANE Select: NM_001854
dbSNP: rs746192125
Type: single nucleotide variant
Location: chr1:103006115 (GRCh38)
Gene constraint: LOEUF 0.349 · pLI 1.00 (gnomAD)
Structure: AlphaFold pLDDT 53.06
Residue 582: the 'disordered' region; the 'triple-helical region' region; the collagen-like 2 domain

Full COL11A1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

COL11A1 p.Pro582Ala Uncertain significance ★★ ⚠ same residue
COL11A1 p.Pro582Leu Uncertain significance ★ ⚠ same residue
COL11A1 c.1245+1G>A Pathogenic/Likely pathogenic ★★ same type
COL11A1 c.1245+1G>T Pathogenic/Likely pathogenic ★★ same type
COL11A1 c.1629+1G>A Likely pathogenic ★★ same type
COL11A1 c.1630-1G>T Pathogenic ★★ same type
COL11A1 c.1791+1G>T Likely pathogenic ★★ same type
COL11A1 c.1900-1G>A Likely pathogenic ★★ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/col11a1-p-pro582ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown